An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

Add Yahoo as a preferred source to see more of our stories on Google. “Debilitating digestive issues dominated my life because I couldn’t go longer than a half hour without going to the bathroom,” ...

(WSPA)—Inflammatory bowel disease (IBD) targets your digestive system. As part of our “Ask the Expert” series, in partnership with Bon Secours St. Francis, 7NEWS spoke with an IBD director to learn ...

The FDA approved Omvoh, a medication that treats ulcerative colitis developed by drugmaker Eli Lilly. The injection is the first treatment for ulcerative colitis that targets p19, a specific protein ...

The American Gastroenterological Association has updated guidance for the treatment of ulcerative colitis to recommend using higher efficacy drugs in earlier stages of treatment, Medscape Medical News ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. This is an exciting time to think about ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

Among patients with IBD in self reported clinical remission, habitual meat intake may affect the risk for flares in those with ulcerative colitis, but not in those with Crohn's disease.

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It causes painful sores and inflammation deep inside your colon and rectum. That can lead to hard-to-manage symptoms like ...